Navigation Links
Bayer and Onyx Begin Enrollment in STORM Trial Studying Nexavar as Adjuvant Therapy for Patients With Liver Cancer
Date:8/21/2008

yer HealthCare combines the global activities of the Animal Health, Consumer Care, Diabetes Care, and Pharmaceuticals divisions. In the U.S., Bayer HealthCare Pharmaceuticals comprises the following business units: Women's Healthcare, Diagnostic Imaging, Specialized Therapeutics, Hematology/Cardiology and Oncology. The company's aim is to discover and manufacture products that will improve human health worldwide by diagnosing, preventing and treating diseases.

About Onyx Pharmaceuticals, Inc.

Onyx Pharmaceuticals, Inc. is a biopharmaceutical company committed to improving the lives of people with cancer. The company, in collaboration with Bayer HealthCare Pharmaceuticals, Inc., is developing and marketing Nexavar(R) (sorafenib) tablets, a small molecule drug. For more information about Onyx, visit the company's website at http://www.onyx-pharm.com.

Forward Looking Statements

This news release may contain forward-looking statements based on current assumptions and forecasts made by Bayer Group or subgroup management. Various known and unknown risks, uncertainties and other factors could lead to material differences between the actual future results, financial situation, development or performance of the company and the estimates given here. These factors include those discussed in Bayer's public reports which are available on the Bayer Web site at http://www.bayer.com. The company assumes no liability whatsoever to update these forward-looking statements or to conform them to future events or developments.

This news release also contains "forward-looking statements" of Onyx within the meaning of the federal securities laws. These forward-looking statements include without limitation, statements regarding the results of the clinical development, safety, regulatory processes, commercialization efforts or commercial potential of Nexav
'/>"/>

SOURCE Onyx Pharmaceuticals, Inc.; Bayer HealthCarePharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Cell Therapeutics, Inc. (CTI) to Hold Conference Call to Discuss Agreement With Bayer Schering Pharma for Access to Phase III Zevalin(R) FIT Trial Data
2. Bayer HealthCare Celebrates 20th Anniversary of Kogenate(R) Product Line and 8 Billion IU Milestone at 2008 WFH World Congress
3. Bayer and Regeneron Dose First Patient in Second Phase 3 Study for VEGF Trap-Eye in Wet Age-Related Macular Degeneration
4. Bayer Issues Additional Guidance to Physicians on Trasylol(R)
5. Genzyme and Bayer Schering Pharma AG, Germany Announce Start of Phase 3 Program with Alemtuzumab for Treatment of Multiple Sclerosis
6. Genzyme and Isis Begin Second Phase 3 Trial Of Mipomersen
7. Light Sciences Oncology Begins Clinical Trials of Litx Therapy in Patients with Enlarged Prostate
8. Catalyst Pharmaceutical Partners, Inc. Begins Enrollment for U.S. Phase II Clinical Trial of CPP-109 in Patients with Methamphetamine Addiction
9. Micromet and Nycomed Begin Formal Preclinical Safety Studies for Antibody MT203 for Inflammatory and Autoimmune Diseases
10. Champions Biotechnology Begins Preclinical Development of Its Lead Oncology Drug Candidate
11. European Enrollment Begins in Pivotal Phase 3 Trial of Novel Combination Medicine Developed by Cogentus Pharmaceuticals
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2015)... , March 27, 2015  WebMD Health ... source of health information, today announced an ... National Action Plan for Combating Antibiotic-Resistant ... emphasized the urgency and importance of addressing ... and global health.    The WebMD ...
(Date:3/26/2015)... March 26, 2015 Huntington Memorial Hospital is ... perform transcatheter aortic valve replacement (TAVR), a minimally invasive ... revolutionary new way to replace an aortic valve without ... lung machine. The procedure is performed by ... Azhil ( Alex) Durairaj , MD, interventional cardiologist and ...
(Date:3/26/2015)... OAK, Mich. , March 26, 2015 ... have performed the Midwest,s first commercial implant of ... Administration for patients with non-valvular atrial fibrillation. The Watchman ... long-term use of blood-thinning warfarin medication to reduce the ... most common heart rhythm disorder affecting more than 5 ...
Breaking Medicine Technology:Exclusive: WebMD Interviews President Obama About Plan for Combating Antibiotic Resistance 2Exclusive: WebMD Interviews President Obama About Plan for Combating Antibiotic Resistance 3Huntington Memorial Hospital Performs Groundbreaking Minimally Invasive Replacement of Heart Valves 2Beaumont Hospital, Royal Oak among first to offer alternative to blood-thinning medications for atrial fibrillation 2Beaumont Hospital, Royal Oak among first to offer alternative to blood-thinning medications for atrial fibrillation 3
... Inc. (Nasdaq: ISTA ), today announced the ... Company,s supplemental New Drug Application (sNDA) for BROMDAY™ (bromfenac ... for the treatment of postoperative inflammation and reduction of ...  ISTA expects to launch BROMDAY (formerly referred to as ...
... 15 The U.S. Food and Drug Administration ... in adult patients with chronic migraine. Chronic migraine is ... on most days of the month. ... http://www.newscom.com/cgi-bin/prnh/20090824/FDALOGO )   "Chronic migraine ...
Cached Medicine Technology:ISTA Pharmaceuticals Receives FDA Approval for BROMDAY™ 2ISTA Pharmaceuticals Receives FDA Approval for BROMDAY™ 3ISTA Pharmaceuticals Receives FDA Approval for BROMDAY™ 4FDA Approves Botox to Treat Chronic Migraine 2
(Date:3/28/2015)... (PRWEB) March 28, 2015 Emergency Medical ... urgent care in Manhattan, recently commemorated its three-year anniversary ... in Manhattan. In addition to 24-hour urgent care, Emergency ... , At this time, Emergency Medical Care’s ... pain, asthma, chest pain, eye injuries, ear infections, fevers, ...
(Date:3/28/2015)... Las Vegas, NV (PRWEB) March 28, 2015 ... surgery experiences re-injury, according to research presented today at ... ) Specialty Day. The study examined the long term ... younger. , “We examined survey data from 242 ... noted lead author Justin P. Roe, MBBS, FRACS, from ...
(Date:3/28/2015)... Andrew Hawley of Vintage Rock Posters Inc., ... posters. The Who and the Doors played together at the ... According to Hawley, “The Who toured the United States heavily ... campuses. Perhaps the most famous Who poster was a poster ... Doors on August 2, 1968 at the Singer Bowl in ...
(Date:3/28/2015)... March 28, 2015 Designers and Professionals ... overlay entitled Scratches 5K from Pixel Film Studios. , ... to any media inside Final Cut Pro X” Said ... saves time and is an effective tool for any ... Overlay Scratches 5K's intuitive grunge overlays. Simply drag title ...
(Date:3/27/2015)... 2015 The Monogamy Method ... Samantha Sanderson and Jason Rogers has just been released ... attention. The commotion surrounding the course's launch has caught ... publish an in-depth review of the new program. , ... in their lives suddenly start pulling away or expressing ...
Breaking Medicine News(10 mins):Health News:Emergency Medical Care Celebrates Three Years of 24/7 Walk-In Urgent Care Services 2Health News:Young Athletes at Greater Risk for Re-Injury after ACL Surgery 2Health News:Avid Collector from Vintage Rock Posters, Inc. Announces His Search For Original 1960's Who Psychedelic Concert Posters. 2Health News:Pixel Film Studios Unveiled Scratches 5k for Final Cut Pro X Editors 2Health News:The Monogamy Method - Review Of Samantha Sanderson & Jason Rogers' Relationship Program Released 2
... executives to add anti-smoking public service announcements to all ... contactmusic.com, Maryland Attorney General // Joseph Curran initiated the ... who watch smoking in movies are more likely to ... to also sign their names on a letter he ...
... of having produced and purified stem cells from human embryos ... the British medical fraternity. ,The Guardian reported Friday that ... tighter curbs on clinics in India that make extravagant claims ... whose claims have evoked some concern here is Geeta Shroff, ...
... What some Japanese newly licensed therapists do is no ... laugh!, ,The first 49 laughing therapists recently passed ... patients laugh to improve their immune system, and in ... professor and pediatrician at the organizing Nihon Medical School., ...
... (BBW) issued for high-risk medication by the FDA, doctors have ... The percentage of patients found to receive // such ... Harvard Medical School and Harvard Pilgrim Health Care. ,The ... BBWs was highly variable, with noncompliance rates soaring from 0.3 ...
... King County Superior Court jury in Seattle, Dr. Charles Momah, ... counts // of rape and two counts of indecent liberties ... ,Momah could face 16 years in prison if convicted ... ,Momah pleaded not guilty last year to two counts of ...
... mother-to-son nerve transplant on Thursday, hoping to restore the use ... Anderson of Atco, N.J., went as planned, and doctors // ... months, said Eric Vohr, a spokesman for Johns Hopkins Hospital. ... months, in about a year they should know if he'll ...
Cached Medicine News:Health News:British Scientists Doubt Delhi Doctor’s Stem Cell Claim 2Health News:Are You Ill? Have A Hard Laugh! 2Health News:Doctors Do Not Excise Sufficient Caution While Prescribing High-Risk Drugs 2Health News:Doctors Finish Mother-To-Son Nerve Surgery 2
Mylar Plate Sealers 100/Box...
OptiTape individual sheets. Optically clear sealing tape for OmniUltra PCR plates. 100 pk....
TD silicone foam compression pad. Use with plates sealed with TDX or OptiTape....
TDX Tape - sealing sheets for polypropylene plates only, 100/PK...
Medicine Products: